Literature DB >> 19114864

Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.

Emilie Lanoy1, Graça M Dores, Margaret M Madeleine, Jorge R Toro, Joseph F Fraumeni, Eric A Engels.   

Abstract

OBJECTIVE: Immunosuppression may increase risk for some skin cancers. We evaluated skin cancer epidemiology among persons with AIDS.
DESIGN: We linked data from population-based US AIDS and cancer registries to evaluate risk of nonkeratinocytic skin cancers (melanoma, Merkel cell carcinoma, and appendageal carcinomas, including sebaceous carcinoma) in 497 142 persons with AIDS.
METHODS: Standardized incidence ratios (SIRs) were calculated to relate skin cancer risk to that in the general population. We used logistic regression to compare risk according to demographic factors, CD4 cell count, and a geographic index of ultraviolet radiation exposure.
RESULTS: From 60 months before to 60 months after AIDS onset, persons with AIDS had elevated risks of melanoma (SIR = 1.3, 95% confidence interval 1.1-1.4, n = 292 cases) and, more strongly, of Merkel cell carcinoma (SIR = 11, 95% confidence interval 6.3-17, n = 17) and sebaceous carcinoma (SIR = 8.1, 95% confidence interval 3.2-17, n = 7). Risk for appendageal carcinomas increased with progressive time relative to AIDS onset (P trend = 0.03). Risk of these skin cancers was higher in non-Hispanic whites than other racial/ethnic groups, and melanoma risk was highest among men who have sex with men. Melanoma risk was unrelated to CD4 cell count at AIDS onset (P = 0.32). Risks for melanoma and appendageal carcinomas rose with increasing ultraviolet radiation exposure (P trend <10 and P trend = 10, respectively).
CONCLUSION: Among persons with AIDS, there is a modest excess risk of melanoma, which is not strongly related to immunosuppression and may relate to ultraviolet radiation exposure. In contrast, the greatly increased risks for Merkel cell and sebaceous carcinoma suggest an etiologic role for immunosuppression.

Entities:  

Mesh:

Year:  2009        PMID: 19114864      PMCID: PMC2728602          DOI: 10.1097/QAD.0b013e3283213046

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  40 in total

1.  Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Authors:  Gary M Clifford; Jerry Polesel; Martin Rickenbach; Luigino Dal Maso; Olivia Keiser; Andreas Kofler; Elisabetta Rapiti; Fabio Levi; Gernot Jundt; Thomas Fisch; Andrea Bordoni; Daniel De Weck; Silvia Franceschi
Journal:  J Natl Cancer Inst       Date:  2005-03-16       Impact factor: 13.506

2.  Sebaceous carcinoma of the eyelid in an immunocompromised patient with Muir-Torre syndrome.

Authors:  F A Stockl; A M Dolmetsch; F Codère; M N Burnier
Journal:  Can J Ophthalmol       Date:  1995-10       Impact factor: 1.882

3.  Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.

Authors:  Giovanni Ponti; Lorena Losi; Carmela Di Gregorio; Luca Roncucci; Monica Pedroni; Alessandra Scarselli; Piero Benatti; Stefania Seidenari; Giovanni Pellacani; Luigi Lembo; Giuseppina Rossi; Massimiliano Marino; Emanuela Lucci-Cordisco; Maurizio Ponz de Leon
Journal:  Cancer       Date:  2005-03-01       Impact factor: 6.860

4.  Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression.

Authors:  T A Maurer; K V Christian; R L Kerschmann; B Berzin; J M Palefsky; D Payne; S K Tyring; T G Berger
Journal:  Arch Dermatol       Date:  1997-05

5.  Sebaceous carcinoma. Tumor progression through mutational inactivation of p53.

Authors:  F Gonzalez-Fernandez; S A Kaltreider; B D Patnaik; J D Retief; Y Bao; S Newman; M H Stoler; P A Levine
Journal:  Ophthalmology       Date:  1998-03       Impact factor: 12.079

6.  Merkel cell carcinoma and melanoma: etiological similarities and differences.

Authors:  R W Miller; C S Rabkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-02       Impact factor: 4.254

7.  Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Authors:  Alina Burgi; Stephanie Brodine; Scott Wegner; Mark Milazzo; Mark R Wallace; Katherine Spooner; David L Blazes; Brian K Agan; Adam Armstrong; Susan Fraser; Nancy F Crum
Journal:  Cancer       Date:  2005-10-01       Impact factor: 6.860

8.  Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid.

Authors:  N Hayashi; M Furihata; Y Ohtsuki; H Ueno
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.

Authors:  T Hasebe; K Mukai; N Yamaguchi; K Ishihara; A Kaneko; Y Takasaki; Y Shimosato
Journal:  Mod Pathol       Date:  1994-01       Impact factor: 7.842

10.  The risk of cancer in HIV-infected people in southeast England: a cohort study.

Authors:  A Newnham; J Harris; H S Evans; B G Evans; H Møller
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

View more
  34 in total

1.  Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers, 1976 to 2005.

Authors:  Graça M Dores; Mark M Huycke; Susan S Devesa; Carlos A Garcia
Journal:  J Am Acad Dermatol       Date:  2010-05-05       Impact factor: 11.527

Review 2.  HIV-Related Skin Disease in the Era of Antiretroviral Therapy: Recognition and Management.

Authors:  Khatiya Chelidze; Cristina Thomas; Aileen Yenting Chang; Esther Ellen Freeman
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

3.  Indoor tanning and melanoma: are gay and bisexual men more at risk?

Authors:  Matthew Mansh; Sarah T Arron
Journal:  Melanoma Manag       Date:  2016-05-19

Review 4.  Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.

Authors:  Paul G Rubinstein; David M Aboulafia; Andrew Zloza
Journal:  AIDS       Date:  2014-02-20       Impact factor: 4.177

5.  Lynch syndrome with exclusive skin involvement: time to consider a molecular definition?

Authors:  Alessandro Vaisfeld; Martina Calicchia; Maria Grazia Pomponi; Emanuela Lucci-Cordisco; Luca Reggiani-Bonetti; Maurizio Genuardi
Journal:  Fam Cancer       Date:  2019-10       Impact factor: 2.375

Review 6.  Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.

Authors:  Teresa Amaral; Ulrike Leiter; Claus Garbe
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

7.  The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: An international assessment.

Authors:  Andreas Stang; Jürgen C Becker; Paul Nghiem; Jacques Ferlay
Journal:  Eur J Cancer       Date:  2018-03-20       Impact factor: 9.162

Review 8.  Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Authors:  Daniela Femia; Natalie Prinzi; Andrea Anichini; Roberta Mortarini; Federico Nichetti; Francesca Corti; Martina Torchio; Giorgia Peverelli; Filippo Pagani; Andrea Maurichi; Ilaria Mattavelli; Massimo Milione; Nice Bedini; Ambra Corti; Maria Di Bartolomeo; Filippo de Braud; Sara Pusceddu
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

Review 9.  Cancer prevention in HIV-infected populations.

Authors:  Priscila H Goncalves; Jairo M Montezuma-Rusca; Robert Yarchoan; Thomas S Uldrick
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

10.  [Management of malignant adnexal neoplasms of the skin].

Authors:  Pia Nagel; Verena Müller; Jochen Utikal
Journal:  Hautarzt       Date:  2021-06-17       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.